| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $213.6M | +9.8% | -16.7% |
| Cost of Revenue | $124.8M | +16.4% | -14.9% |
| Gross Profit | $88.8M | +1.7% | -19.2% |
| R&D Expense | $24.6M | -9.0% | -6.6% |
| SG&A Expense | $23.3M | +42.9% | +17.4% |
| Operating Income | $25.0M | -13.6% | -46.7% |
| Pre-tax Income | $30.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $187.5M | +8.0% | +56.2% |
| Short-term Investments | $262.1M | -30.3% | -42.9% |
| Accounts Receivable | $147.6M | +6.3% | -19.6% |
| Inventory | $324.3M | +4.4% | +11.5% |
| Current Assets | $984.0M | -7.6% | -12.3% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $124.9M | — | — |
| Capital Expenditures | $9.0M | — | — |
| Investing Cash Flow | $37.2M | — | — |
| Financing Cash Flow | -$99.9M | — | — |
| Free Cash Flow | $115.9M | — | — |
| -13.8% |
| -45.5% |
| Income Tax | $4.2M | +15.0% | -38.7% |
| Net Income | $26.0M | -17.2% | -46.5% |
| EPS (Basic) | $0.83 | -16.2% | -44.3% |
| EPS (Diluted) | $0.83 | -15.3% | -44.3% |
| $1.35B |
| +2.1% |
| +1.0% |
| Current Liabilities | $199.0M | +12.4% | -21.1% |
| Total Liabilities | $331.8M | +10.2% | -8.5% |
| Stockholders' Equity | $1.02B | -0.2% | +4.6% |